about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsAmantadine and rimantadine for influenza A in children and the elderlyInfluenza vaccines for preventing acute otitis media in infants and childrenVaccines for preventing influenza in multiple sclerosis patientsEffectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analysesT-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective VaccinesSeasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature reviewInfluenza vaccination in the elderly: why are the overall benefits still hotly debated?Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic reviewInfluenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza VaccinesApplication of radiation technology in vaccines developmentReducing hospital admissions from nursing homes: a systematic reviewEffectiveness of influenza vaccination for preventing influenza-related complications in people with asthma: a systematic review protocolTreating and preventing influenza in aged care facilities: a cluster randomised controlled trialRisk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort studyInfluenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for biasEstimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in CanadaSocial determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative dataHigh Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd Immunity.Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults.Enhancement of collective immunity in Tokyo metropolitan area by selective vaccination against an emerging influenza pandemic.Big Data Usage Patterns in the Health Care Domain: A Use Case Driven Approach Applied to the Assessment of Vaccination Benefits and Risks. Contribution of the IMIA Primary Healthcare Working Group.Effectiveness of post-exposition prophylaxis with oseltamivir in nursing homes: a randomised controlled trial over four seasons.Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?One versus two doses: What is the best use of vaccine in an influenza pandemic?Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia.Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case-control study.Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controlsNovel viral vectored vaccines for the prevention of influenza.Medical and economic burden of influenza in the elderly population in central and eastern European countries.The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation studyEffects of vaccination and the new neuraminidase inhibitor, laninamivir, on influenza infection.Public health impact and economic benefits of quadrivalent influenza vaccine in Latin AmericaCoverage and Influencing Determinants of Influenza Vaccination in Elderly Patients in a Country with a Poor Vaccination Implementation.Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: estimation in a French web-based cohort.Annual public health and economic benefits of seasonal influenza vaccination: a European estimate
P2860
Q21090775-067A4827-8157-4498-8F3C-F40C7CEA405AQ24187883-3DB26353-334C-4552-BE0C-005068D7903EQ24201197-761DEDE8-AF9A-4676-8671-A228AFBFBE65Q24201719-6D9C16CA-C3FA-413C-A49F-48E3F21902ADQ24614487-370869E4-D88D-4728-A978-31D8D68ADD18Q26768539-85AAA05F-D772-4A94-9389-37C743FED116Q26769664-622AC5BF-9E57-40CA-ADDD-8B23116B7E39Q26770659-02B78FBD-F3B6-4D62-9435-929E8402F90BQ26782188-2F18AB96-A6C7-4138-83AA-8D857345D5C4Q26783844-2FA57508-801A-42B5-9ACB-6864D0727D7EQ26798165-B9A7EC54-D725-42B8-A2F2-C1070A841C29Q26849486-277DD1FA-068E-45D9-AB9C-67B21B1DD42AQ28077038-78302F68-6BDD-4871-87BD-AA7FB6BA5F7DQ28484471-53A6F57D-E3D4-4D60-A7F2-9983CD019322Q28604186-6A682F0E-84BE-4311-90FC-0A346C5F4595Q28742116-AE6B93F1-FDE3-453F-8C74-8653BACFF998Q28742771-5602A2F4-0435-4B4F-919C-E530C2AA987DQ30000798-1CA9444C-7DE3-4FDA-8DC0-9446F3D7D252Q30151694-FC20E3FD-D35F-4D47-9C54-99ECC57CCFFCQ30248365-58647C4B-C12A-440E-9791-FBA5C9F7761CQ30353828-F96E44EA-EAA9-429C-BE22-C2A8212963DEQ30365708-4D9DFAB8-1D96-48FB-9E8D-942D09BB5EACQ30366675-0CB719D1-0680-4129-BAB1-636CD89765E9Q30371807-CF39D48C-FBEC-4AC1-8C76-97D28C81535FQ30381774-371C1955-1EBC-4FA0-BB82-9A6E3CFFDF19Q30382026-86528891-0B41-4D9F-9812-633D75D05D89Q30390901-C6FEFC08-4F1B-4786-ADE8-9644F85B407CQ30403801-FC73A074-361B-4F6E-9669-E76024DDE656Q30404989-39D8007C-C915-4C15-A9DC-77A28448DAA1Q30406437-93A136BE-8864-40E6-A595-BB16BD9DEC8AQ30408530-8677E9F3-DEE3-4968-BF70-F11D3B238713Q30417417-09058591-936D-40EF-A086-80C26FE5A998Q30418570-EEF39E46-D388-4A7D-8EB2-D555D1F63A8FQ30486450-64F343E4-A4EE-46D2-A470-A76B605A6FBCQ31148484-EB48EB9C-9A8F-436F-8D3F-7B86D371DF75Q31155532-115F08E1-19C9-4DBC-ACE1-CDA20C3CC721Q33601906-9CC82C0E-4703-472C-A9BE-CEA350529841Q33840055-47D9EE65-DC33-4664-9FE8-03AE9D1F2354Q34033876-1C90DF8E-5A35-48F3-919B-775BF4E2E323Q34076633-8ED61947-A91E-4E95-B965-5AE21D222AC5
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vaccines for preventing influenza in the elderly
@ast
Vaccines for preventing influenza in the elderly
@en
Vaccines for preventing influenza in the elderly
@en-gb
Vaccines for preventing influenza in the elderly
@nl
type
label
Vaccines for preventing influenza in the elderly
@ast
Vaccines for preventing influenza in the elderly
@en
Vaccines for preventing influenza in the elderly
@en-gb
Vaccines for preventing influenza in the elderly
@nl
prefLabel
Vaccines for preventing influenza in the elderly
@ast
Vaccines for preventing influenza in the elderly
@en
Vaccines for preventing influenza in the elderly
@en-gb
Vaccines for preventing influenza in the elderly
@nl
P2093
P2860
P3181
P1476
Vaccines for preventing influenza in the elderly
@en
P2093
Eliana Ferroni
Lubna A Al-Ansary
Roger E Thomas
Sarah Thorning
Tom Jefferson
P2860
P356
10.1002/14651858.CD004876.PUB3
P577
2010-02-17T00:00:00Z